abstract |
The invention discloses a compound of formula I, a preparation method of the compound of formula I and its use as a genotoxic impurity reference substance in the quality inspection of saphenamide products. The quality of safinamide sulfonate, thereby ensuring the safety and effectiveness of the clinical use of safinamide mesylate. |